October 31, 2013
Dr Nakagawa (left) Rejoining a powerful health ministry advisory panel after a four-year hiatus, Toshio Nakagawa, vice president of the Japan Medical Association, says that he is “against” the full and permanent introduction of the premium for new drug development...read more